Loading...
Loading...
BLCO| Name | Value |
|---|---|
| Revenues | 1,196.0M |
| Cost of Revenue | 536.0M |
| Gross Profit | 660.0M |
| Operating Expense | 595.0M |
| Operating I/L | 43.0M |
| Other Income/Expense | -101.0M |
| Interest Income | 4.0M |
| Pretax | -58.0M |
| Income Tax Expense | 66.0M |
| Net Income/Loss | -124.0M |
Bausch + Lomb Corporation is a global eye health company with three main segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment offers a wide range of contact lenses and care products, including daily disposable and frequently replaced lenses, over-the-counter eye drops, and vitamins. The Ophthalmic Pharmaceuticals segment provides proprietary and generic pharmaceutical products for post-operative treatments and various eye conditions. The Surgical segment offers tools and technologies for cataract and retinal eye conditions treatment, intraocular lenses, and surgical instruments. The company generates revenue through the sale of contact lenses, pharmaceutical products, and surgical equipment.
